3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
25
Leukemia, Myeloid, Acute
17
Leukemia
11
Myelodysplastic Syndromes
10
Recurrence
8
Lymphoma
8
Burkitt Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Multiple Myeloma
6
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Sarcoma
4
Lymphoma, T-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Primary Myelofibrosis
3
Neoplasms, Plasma Cell
3
Leukemia, Myeloid
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Waldenstrom Macroglobulinemia
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Interventions
Paclitaxel
2
Kidney Transplantation
2
Cyclophosphamide
2
Azacitidine
2
veliparib
1
trifluridine tipiracil drug combination
1
trebananib
1
safinamide
1
sacubitril and valsartan sodium hydrate drug combination
1
rubitecan
1
ripretinib
1
regorafenib
1
pomalidomide
1
pevonedistat
1
osimertinib
1
mirabegron
1
glucarpidase
1
gamma-Glutamyl Hydrolase
1
dabrafenib
1
copanlisib
1
belinostat
1
belantamab mafodotin
1
Whole-Body Irradiation
1
Topotecan
1
Taxes
1
Sitagliptin Phosphate
1
Rituximab
1
Pharmacogenomic Testing
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Renal Insufficiency
×
Methotrexate
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts